New cancer drug combo tested in patients who ran out of options
NCT ID NCT05954871
Summary
This early-stage study tested the safety of a new drug called GDC-1971 when given alongside standard cancer medications. It involved 10 patients with advanced lung or colorectal cancer whose disease had progressed despite previous treatments. The main goal was to find a safe dose and understand how the body processes the drug combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Border Medical Oncology
Wodonga, New South Wales, 3690, Australia
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
START South Texas Accelerated Research Therapeutics-San Antonio
San Antonio, Texas, 78229, United States
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
St Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065, Australia
Conditions
Explore the condition pages connected to this study.